Par Drugs & Chemicals
Par Drugs & Chemicals Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Par Drugs & Chemicals
Start SIPPar Drugs & Chemicals Investment Rating
-
Master Rating:
-
Par Drugs and Chemicals has an operating revenue of Rs. 95.75 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of 16% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 20% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 24 | 23 | 25 | 24 | 22 |
| Operating Expenses Qtr Cr | 19 | 20 | 19 | 20 | 18 |
| Operating Profit Qtr Cr | 5 | 3 | 6 | 4 | 5 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 1 | 1 | 1 | 1 |
| Net Profit Qtr Cr | 3 | 2 | 4 | 2 | 2 |
Par Drugs & Chemicals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹200.51
- 50 Day
- ₹183.34
- 100 Day
- ₹171.61
- 200 Day
- ₹164.66
- 20 Day
- ₹202.79
- 50 Day
- ₹175.15
- 100 Day
- ₹164.14
- 200 Day
- ₹161.11
Par Drugs & Chemicals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹214.64 |
| Second Resistance | ₹218.92 |
| Third Resistance | ₹223.69 |
| RSI | 67.03 |
| MFI | 38.28 |
| MACD Single Line | 10.98 |
| MACD | 9.81 |
| Support | |
|---|---|
| First Resistance | ₹205.59 |
| Second Resistance | ₹200.82 |
| Third Resistance | ₹196.54 |
Par Drugs & Chemicals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 34,833 | 2,673,084 | 76.74 |
| Week | 21,439 | 1,533,975 | 71.55 |
| 1 Month | 42,775 | 2,363,339 | 55.25 |
| 6 Month | 20,779 | 1,132,658 | 54.51 |
Par Drugs & Chemicals Result Highlights
Par Drugs & Chemicals Synopsis
NSE-Medical-Diversified
Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 95.75 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2023. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.| Market Cap | 259 |
| Sales | 96 |
| Shares in Float | 0.32 |
| No of funds | |
| Yield | 0.72 |
| Book Value | 3.64 |
| U/D Vol ratio | 2.7 |
| LTDebt / Equity | |
| Alpha | 0.18 |
| Beta | 0.24 |
Par Drugs & Chemicals
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 74.21% | 74.21% | 74.21% | 74.21% |
| Mutual Funds | ||||
| Insurance Companies | ||||
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | ||||
| Individual Investors | 22.05% | 21.98% | ||
| Others | 3.74% | 3.81% | 25.79% | 25.79% |
Par Drugs & Chemicals Management
| Name | Designation |
|---|---|
| Mr. Falgun Vallabhbhai Savani | Chairman & Managing Director |
| Mr. Jignesh Vallabhbhai Savani | Executive Director & CEO |
| Mr. Ghanshayambhai Bhagvanbhai Savani | Whole Time Director |
| Mrs. Nayna Jignesh Savani | Non Executive Director |
| Mr. Pravin Manjibhai Bhayani | Independent Director |
| Mrs. Kajal Chintanbhai Vaghani | Independent Director |
| Mr. Krishna Mitulbhai Shah | Independent Director |
| Mrs. Bintal Bhaveshkumar Shah | Independent Director |
Par Drugs & Chemicals Forecast
Price Estimates
Par Drugs & Chemicals FAQs
What is Share Price of Par Drugs & Chemicals ?
Par Drugs & Chemicals share price is ₹210 As on 10 June, 2023 | 17:23
What is the Market Cap of Par Drugs & Chemicals ?
The Market Cap of Par Drugs & Chemicals is ₹258.8 Cr As on 10 June, 2023 | 17:23
What is the P/E ratio of Par Drugs & Chemicals ?
The P/E ratio of Par Drugs & Chemicals is 22.8 As on 10 June, 2023 | 17:23
What is the PB ratio of Par Drugs & Chemicals ?
The PB ratio of Par Drugs & Chemicals is 3.6 As on 10 June, 2023 | 17:23